Nothing Special   »   [go: up one dir, main page]

GB0509829D0 - Compound - Google Patents

Compound

Info

Publication number
GB0509829D0
GB0509829D0 GBGB0509829.8A GB0509829A GB0509829D0 GB 0509829 D0 GB0509829 D0 GB 0509829D0 GB 0509829 A GB0509829 A GB 0509829A GB 0509829 D0 GB0509829 D0 GB 0509829D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0509829.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guys and St Thomas NHS Foundation Trust
Original Assignee
Guys and St Thomas NHS Foundation Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guys and St Thomas NHS Foundation Trust filed Critical Guys and St Thomas NHS Foundation Trust
Priority to GBGB0509829.8A priority Critical patent/GB0509829D0/en
Publication of GB0509829D0 publication Critical patent/GB0509829D0/en
Priority to PCT/GB2006/001767 priority patent/WO2006120472A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0509829.8A 2005-05-13 2005-05-13 Compound Ceased GB0509829D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0509829.8A GB0509829D0 (en) 2005-05-13 2005-05-13 Compound
PCT/GB2006/001767 WO2006120472A2 (en) 2005-05-13 2006-05-12 Novel beta-steroid compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0509829.8A GB0509829D0 (en) 2005-05-13 2005-05-13 Compound

Publications (1)

Publication Number Publication Date
GB0509829D0 true GB0509829D0 (en) 2005-06-22

Family

ID=34708148

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0509829.8A Ceased GB0509829D0 (en) 2005-05-13 2005-05-13 Compound

Country Status (2)

Country Link
GB (1) GB0509829D0 (en)
WO (1) WO2006120472A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1902316A4 (en) * 2005-07-12 2009-06-03 Univ Tulane Method of treating human volume expansion mediated hypertension employing resibufogenin
GB0713463D0 (en) 2007-07-11 2007-08-22 Btg Int Ltd Modulators of hypoxia inducible factor-1 and related uses
US8962602B2 (en) 2010-04-27 2015-02-24 Pharma Mar, S.A. Anticancer steroidal lactones unsaturated in position 7 (8)
TWI466674B (en) * 2011-04-11 2015-01-01 Univ Kaohsiung Medical Bioactivity composition of reevesia formosana
CN114395011B (en) * 2022-02-11 2023-04-25 上海中医药大学 Preparation method of natural bufogenin compound
CN114933624B (en) * 2022-05-24 2024-02-20 大连理工大学 Artificial synthesis method of natural product (+) -digitonin
CN117491535B (en) * 2023-12-22 2024-03-22 山东省食品药品检验研究院 Quality evaluation method of external gel bulk drug of lindera root

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380624A (en) * 1981-07-31 1983-04-19 Advance Biofactures Corp. Novel isomers of bufalin and resibufogenin and their preparation

Also Published As

Publication number Publication date
WO2006120472A3 (en) 2007-05-10
WO2006120472A2 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
GB0500492D0 (en) Compound
GB0513702D0 (en) Compound
EP1876179A4 (en) Thienopyrimidone compound
GB0506133D0 (en) Compound
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0520955D0 (en) Compound
HK1117739A1 (en) Motilide compounds
GB0508463D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0512429D0 (en) Novel compound
GB0525323D0 (en) Compound
GB0509829D0 (en) Compound
GB0616173D0 (en) Compound
GB0512325D0 (en) Compounds
GB0508460D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0601851D0 (en) Compounds
GB0501985D0 (en) Compounds
GB0516378D0 (en) Compound
GB0524685D0 (en) Compound
EP1961756A4 (en) Novel bisboron compound
GB0516314D0 (en) Compound
GB0519485D0 (en) Compounds
GB0518114D0 (en) Compounds
GB0502484D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)